Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Jane M
    Senior Member
    • Aug 2011
    • 239

    How to compare two tumor samples?

    Hello,

    I've worked on the comparison of a normal sample and a tumor sample in cancer data. I wanted to perform a direct comparison to detect somatic mutations, so I used VarScan2.
    Now, I would like to compare 2 tumor samples, one untreated and one treated, in order to study the impact of a treatment.

    I don't know if I can use VarScan2 here again, for a direct comparison. Maybe, the model is not suitable. I'm thinking about performing an independent analysis on both samples, but I would prefer a simultaneous comparison... I would like to ask you how do you do?
    Thank you for your feedback,
    Jane
  • Jane M
    Senior Member
    • Aug 2011
    • 239

    #2
    Any idea?

    Comment

    • honey
      Senior Member
      • Feb 2010
      • 151

      #3
      Tumor samples

      I would think same approach as you sued for normal vs tumor now you are comparing condition

      Comment

      • Jane M
        Senior Member
        • Aug 2011
        • 239

        #4
        You mean, using varscan2 with untreated tumor sample as "normal" and treated tumor sample as "tumor"?
        I don't know enough the model in VarScan to be sure that for the "normal", there is no assumption that prevents the use of tumor instead...
        I don't know if I'm clear, do you see what I mean?

        Comment

        • arkal
          advancing one byte at a time!
          • Jun 2011
          • 56

          #5
          Originally posted by Jane M View Post
          You mean, using varscan2 with untreated tumor sample as "normal" and treated tumor sample as "tumor"?
          I don't know enough the model in VarScan to be sure that for the "normal", there is no assumption that prevents the use of tumor instead...
          I don't know if I'm clear, do you see what I mean?
          I don't think there should be much of a problem using the untreated as the "normal".... after all, all you want to do is test one against the other! Consequently, if you're still too apprehensive about doing that, you can use the untreated one as a reference and use publically available variant callers to call variants in your treated sample against your reference. check the first "sticky" post on this forum for a bunch of tools.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...